LEX-WK-CMYCD9R8crawled 2026-02-16 12:17Z
After FDA’s Policy Shift on Artificial Colors, State Enforcement and Private Litigation Risks Linger
Matthew Berns · Namrata Kang · Regulatory Oversight · Published February 16, 2026
Work details
- author
- Matthew Berns · Namrata Kang
- firm or organization
- Troutman Pepper Locke
- publication
- Regulatory Oversight
- practice area
- Administrative and Regulatory · Food, Drug & Agriculture · Health Care and Life Sciences
- published
- 2026-02-16
Citation
Matthew Berns, Namrata Kang, After FDA’s Policy Shift on Artificial Colors, State Enforcement and Private Litigation Risks Linger, Regulatory Oversight (February 16, 2026) [The Library at LexBlog, LEX-WK-CMYCD9R8, lexpid.org/CMYCD9R8]